SelectScience InterviewsLife Sciences

Developing Flavivirus Vaccines with Multiplexed Immunogenicity Screening

17 Dec 2018
Developing Flavivirus Vaccines with Multiplexed Immunogenicity Screening

Flaviviruses are a group of single-stranded RNA species that present an unmet clinical need for vaccines. Listen to Eric Shaw, of Takeda Vaccines, discuss his company’s efforts in developing multiplexed FLAVI screening assays, with 13 different antigens spanning seven different species, to advance research and development in the field.

Other videos from SelectScience

Links